chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; tenderness at injection site; fatigue; headache; This is a spontaneous report from a contactable consumer (patient) received via a sales representative.   A 12-year-old female patient received second dose of BNT162B2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2, lot number unknown, via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. The patient experienced sore arm, tenderness at injection site, fatigue and headache, 20 hours after receiving her second Covid-19 vaccine dose.  It was reported that events took place after use of product. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I received my 5th dose on 12/09/2022. My COVID-19 symptoms started on 12/14/2022 at night around 10:00PM. I had a sore throat. The next day 12/15/2022 I had cough, fatigue, chills, fever, severe headaches, and body aches. On 12/19/2022 I did a COVID-19 home test which was positive. In the afternoon I called doctor around 3:00PM. He prescribed with PAXLOVID for 5 days and TESSALON PERLES.
Chills- 15 hours Headache- 15 hours- Tylenol  Muscle aches- 24 hours Sweats after chills- 4 hours
hard time breathing; sick; dizzy; sweating profusely; sore all over; throwing up for a week,; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard time breathing), ILLNESS (sick), DIZZINESS (dizzy), HYPERHIDROSIS (sweating profusely) and MYALGIA (sore all over) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0281921A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD and Fibromyalgia.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (hard time breathing), ILLNESS (sick), DIZZINESS (dizzy), HYPERHIDROSIS (sweating profusely), MYALGIA (sore all over) and VOMITING (throwing up for a week,). At the time of the report, DYSPNOEA (hard time breathing), ILLNESS (sick), DIZZINESS (dizzy), HYPERHIDROSIS (sweating profusely), MYALGIA (sore all over) and VOMITING (throwing up for a week,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received contains no new information.
Patient was vaccinated with an expired (past beyond use date) Pfizer bivalent vaccine that. The vaccine was received and moved to our fridge on 5/3/23. Beyond use date was 7/2/23 and the vaccine was administered to the patient on 7/27/23.
Injection site redness, swelling and pain (tenderness). Some fever 100 deg. F. This has continued till now (9 days after injection).
This spontaneous report as received from a Certified Medical Assistant refers to a patient of unknown age and gender. On 29-SEP-2014, the patient was inadvertent vaccinated with a dose of VARIVAX (Merck), 0.5 ml, subcutaneously instead of ZOSTAVAX. No adverse experience reported. Additional information has been requested.
This spontaneous report was received from a physician via a company representative and refers to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history and drug reactions or allergies were unknown. On an unknown date (reported as "1 to 2 years ago"), the patient was vaccinated with a dose of ZOSTAVAX vial, subcutaneously (exact dose, lot # and expiry date were not reported) to prevent shingles. Other suspect therapies included sterile diluent (STERILE DILUENT) (exact dose, lot # and expiry date were not reported), administered together with ZOSTAVAX. On an unknown date, the patient developed a severe case of shingles. They sought medical attention by contacting the office. The outcome of the event and causal relationship between the event and suspect therapies were not reported. Product quality complaint was not involved. Additional information has been requested.
Left deltoid soreness, mild to moderate, resolving with exercise; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 428068) via an unspecified route of administration in the arm left on 14Apr2021 at 13:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 16:00, the patient experienced Left deltoid soreness, mild to moderate, resolving with exercise. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event left deltoid soreness, mild to moderate, resolving with exercise was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse concerning an 8 weeks old patients who was intended to receive RECOMBIVAX HB and instead on 16-APR-2009 were inadvertently vaccinated IM with a 0.5 mL dose of VAQTA.  The nurse stated that this was due to a human error and not to product confusion.  This is one of several reports received from the same source.  Additional information has been requested.
fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and FATIGUE (fatigue) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Patient never had COVID-19 positive diagnosis or test and no allergy including medications, food and other products.  The patient's past medical history included Heart disease, unspecified (Started since 30 years ago and no recent change in status such as improvement or worsening.) and Open heart surgery. Previously administered products included for Product used for unknown indication: Flu shot (Flu shot were given one month ago.). Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Type 2 diabetes mellitus (Started since 4 years ago and no recent change in status such as improvement or worsening.) and Blood pressure high (Started since 30 years ago and no recent change in status such as improvement or worsening.). Concomitant products included METFORMIN and DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA) for Diabetes, HYDROCHLOROTHIAZIDE for Diuretic effect.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). On 07-Feb-2021, PYREXIA (fever) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Heart rate: 90 and 100 (High) After 1 dose pulse raised between 90 and 100 for 3 days..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       It was reported that patient did not experienced a similar event in the past and this adverse event didnt cause patient to seek medical care including office visit, Urgent care, ER and hospitalized. Other concomitant medicine: Beta Blockers for an unknown indication. No treatment information were provided by the reporter.   This case was linked to MOD-2022-535621, MOD-2022-535624, MOD-2022-535625 (Patient Link).
No adverse events noted... Pt. had mixed initial series - the facility was out of Novavax vaccine and pfizer was given
Patient is G4P1(1,0,0,1) who was 32 weeks and 2 days gestation at the time of vaccination. No adverse effects to fetus have been noted.  Patient received Adacel vaccination in right deltoid. Patient tolerated injection well. No pain at injection site. Since injection, patient has had worsening soreness around her shoulder/rotator cuff. Patient experiences great discomfort with any range of motion, such as putting on clothes or opening doors. Patient has been referred to physical therapy for this issue. If issue persists after the birth of her child, patient may undergo imaging of her shoulder but none has been completed at this point.
This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), CHILLS (Chills), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever), CHILLS (Chills), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Heartbeat has been in the upper 120; Dizziness; This is a spontaneous report from a contactable consumer (patient's parent). A female patient of unspecified age received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on 10Aug2021 as single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. On 10Aug2021 at 19:00, patient experienced heartbeat has been in the upper 120 and dizziness. Reporter seriousness for both events was unspecified. Lab test included heartbeat was in upper 120 on 10Aug2021. The outcome of events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Case completed primary Covid series in April 2021, then was hospitalized for Covid in October 2021. COVID-19 Assessment & Plan Hospitalized for 10/4 through 10/7, treated with dexamethasone, discharged to home with wife's assistance, without supplemental oxygen.  Return this admission due to progressive weakness, poor mobility at home, confusion, diminished orientation. --will go home on 1L oxygen. Consider f/u CXR.
After getting vaccine on the day of 11/11/21 about hour or so later I felt my lip twitch or tremor like. About a week less later, 11/16/1021 about 3;00 am in the morning. I had a SEVERE EXTREME Headache woke me out of my sleep, I layed on my floor, pain was EXTREME hurt terribly. light and sound was unbearable and went away after laying there for two or three hours. 12/15/2021 SEVERE Headache, painful not as severe as previous headache. Went to emergency room. ABNORMAL CT Scan. headaches has been ongoing since vaccination. Headache pain, and pressure.
Vials that were more than 30 days in refrigerator administered to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vials that were more than 30 days in refrigerator administered to patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vials that were more than 30 days in refrigerator administered to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vials that were more than 30 days in refrigerator administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.
Next day headache, body ache, chills, woke at 6:30am feeling this way. Just started today.
had high fever, neck pain, vomiting, severe h/a, OM; MD felt was related to vax; adm to hosp 17JUL92; d/c dx viral synd & lt OM; also dehydration & nausea;
Information has been received from a licensed practical nurse concerning an adult male pt who on approx 20Oct04 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 0386P). Subsequently, the pt developed an injection site reaction that included redness, warmth and pain. Unspecified medical attention was sought. The pt was recovering. No product quality complaint involved. No further information is expected.
pt recv vax 17MAY95 & the next day pt exp a stiff neck & achiness;reporter indicated that there was a concern w/the particular lot of vax;
Mom noted onset of rash on chest and neck today. Also noted swelling at site of injections on (L) leg. Dr. today examined the areas and noted redness and swelling at injection sites approximately .5 cm diameter at each site. No specific treatments. Will mon. for improvement.
A skin rash appeared at the area where the shot was administered.  It was approximately 2 x 3 inches in size.  It was red and itchy.  There was also soreness associated with it, similar to the soreness experienced right after receiving the shot.   The rash cleared up after 4 days.
The patient was injected with a syringe and after injection the intern believed that there was nothing in the syringe so she proceeded to give another injected of the Covid vaccine. the patient may have been injectedtwice
temperature, sore throat, slight chest tightening, shivering, fatigue for 2 days until 5/2/2022.
BEGINNING AROUND 11:00 AM, SOME DIFFICULTY SWALLOWING & SEVERE ACHES. LATER IN THE DAY, AROUND 1:00 PM, RAPID HEARTBEAT, TROUBLE BREATHING & SEVERE BLOODSHOT EYES. VISITED EMERGENCY ROOM FOR TREATMENT WITH SYMPTOMS AROUND 2:30 PM.  E.R. VISIT (TREATMENT SEGMENT) LASTED 6+ HOURS. A FEW DAYS LATER, DEVELOPED HIVES THAT LASTED NEARLY ONE WEEK.
22 hrs after 2nd vaccination extreme fatigue; 22 hrs after 2nd vaccination extreme fatigue, body aches.; 22 hrs after 2nd vaccination extreme fatigue, body aches, SOB; 22 hrs after 2nd vaccination extreme fatigue, body aches, SOB, vertigo; 22 hrs after 2nd vaccination extreme fatigue, body aches, SOB, vertigo and migraine. Have continued vertigo and migraine improving but have had 1-2 weekly since onset of symptoms.; This is a spontaneous report from a contactable other healthcare professional (patient). A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3246) via an unspecified route of administration in the left arm on 07Jan2021 at 14:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included estrogens conjugated, medroxyprogesterone acetate (PREMPRO) and escitalopram oxalate (LEXAPRO) from unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EK5730) via an unspecified route of administration in the left arm on 17Dec2020 at 12:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Jan2021 at 12:00 (22 hours after the 2nd dose), the patient experienced  extreme fatigue, body aches, shortness of breath, vertigo and migraine. The patient reported that she was continued with vertigo and migraine which improved but had 1-2 times weekly since onset of symptoms. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  The clinical outcome of the events extreme fatigue, body aches, shortness of breath, vertigo and migraine were  recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: vaccine date for first dose of bnt162b2 updated as 17Dec2020 in narrative.
painful band on left of chest (bra line); warm flush; dizzy; numbness with heavy feeling in left arm and hand.; vaccine the numbness; needles (tingly); hyper sensitivity (feels like sunburn or really cold) also affects my left body, left arm & leg and left face.; Bad headache; After 2 weeks affect my joints, jaws, teeth and muscles on left side.; Painful with cramps at times.; This is a spontaneous report from a non-contactable consumer. This 51-year-old female consumer reports that: A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8736 and expiry date were not reported, Solution for injection), via an unspecified route of administration, administered in left arm, on 23May2021 (at the age of 51-year-old) as an unknown, single dose for COVID-19 immunization. The patient medical history was not reported. The patient did not receive any other vaccine in four weeks. The patient was not tested COVID prior and post vaccination. The concomitant medications included Irbesartan. On 23May2021 (same day of vaccination), within first 10 minutes of vaccine experienced painful band on left of chest (bra line), warm flush and dizzy, pins & needles, numbness with heavy feeling in left arm and hand. By 11th day after vaccine the numbness, pins and needles (tingly) and hypersensitivity (feels like sunburn or really cold) also affects her left body, left arm & leg and left face. Bad headache that lasts for a couple days has happened 4 times in a month. After 2 weeks affect her joints, jaws, teeth, and muscles on left side. Painful with cramps at times. As of 4 weeks post 1st vaccine it was still noticeable. It was unknown that patient received any treatment for events. Due to events patient needs to visit doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
pretty red spot the half the size of a silver dollar that got bigger; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger). On 22-Jan-2021, ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger). On 22-Jan-2021, ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
injection done 12/17. next day, developed chest pressure radiating to arms. continues to have intermittent chest tightness 5-15 min daily, unrelated to exercise. possible myocarditis.
I went into the er for high fever and cough I was already on doxycycline (sorry forgot to put above) for infection and I didn?t want to go septic again. Er staff thought I had covid so they were going to do some tests. I have a history of PEs and DVTs so they did a leg ultrasound and than they did a chest ct with dye.  I was fine for the actual test but after the chest ct I sat up and I told the tech my hands where burning more that usual.  She asked if I was ok and I said no something is truly wrong.  I was told I coded right there. I was without oxygen for several minutes. They Brought me back and put me in a medical induced coma for several days.  They are saying it?s the ct due that caused the issue but I have had this test done at least 20 times and never had a reaction.  From nothing to full anaphylactic code.  Can the shot change your body?
Initial report received from a healthcare professional on 03 October 2013. A female patient, whose age is greater than 65, had received an intramuscular dose of FLUZONE HD, batch number U4764AA, dose number was not reported in left deltoid on 02 October 2013. On 02 October 2013, 8 hours after vaccination, the patient experienced chills, nausea, vomiting, and health anxiety. Corrective treatment and laboratory investigations were not reported. At the time of this report, the patient was recovered from chills, nausea, vomiting. And health anxiety was not recovered. Documents held by sender: none.
Pt. rec'd AFLURIA and PNEUMOVAX on 10/23/13 both in left arm. Late that evening, area became tender and swollen, spreading to underarm the next day.
Lower leg weakness - left > right - 5 days after vaccination and persisting for a few weeks (similar reaction each of the last 3-4 yrs after INFLUENZA vaccine). In past, yes. Still symptomatic now.
Case number PHEH2012US016350 is an initial spontaneous report received from a medical assistant on 17 Aug 2012 with a follow-up received on 11 Sep 2012: This report refers to 26-year-old female patient. Her medical history included asthma and pneumonia. Her vaccination history was unknown. She was vaccinated with MENVEO (batch number: A11071) subcutaneously in to left arm on 15 Aug 2012 following which she experienced a localized reaction. The outcome of the event was reported as complete recovery. The seriousness and causality were not reported. No additional information was available. Follow up information received from the medical assistant on 11 Sep 2012: Patient demographics, vaccinated arm, relevant medical history, outcome updated.